Pacific Biosciences Narrows FY2026 Sales Guidance from $155.000M-$165.000M to $155.000M-$160.000M vs $158.871M Est
Benzinga Newsdesk 18 hours ago
NewsGuidance
Pacific Biosciences (NASDAQ:PACB) narrows FY2026 sales outlook from $155.000 million-$165.000 million to $155.000 million-$160.000 million vs $158.871 million estimate.
Pacific Biosciences (NASDAQ:PACB) narrows FY2026 sales outlook from $155.000 million-$165.000 million to $155.000 million-$160.000 million vs $158.871 million estimate.